Morgan Stanley Emerging Markets Domestic Debt Fund, Inc.

NYSE:EDD

4.87 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22011 Q42011 Q22010 Q42010 Q22009 Q42009 Q22008 Q42008 Q22007 Q42007 Q2
Revenue 15.9932.3588.158-77.673-14.777.29610.874-4.2247.81-21.42527.16230.08732.55331.59627.237.929.832.240.945.243.85458.460.761.569.46867.266.875.747113.17988.21
Cost of Revenue 2.352.4272.4372.5532.9183.3063.4343.333.7163.8938.3268.638.6668.617.57.87.28.29.68.38.59.610.39.99.710.29.810.19.28.67.19.310.511.60.3
Gross Profit 13.643-0.0695.721-80.226-17.6883.997.44-7.5544.094-25.31818.83621.45723.88722.98619.730.122.62431.336.935.344.448.150.851.859.258.257.157.667.139.9103.868.576.60.7
Gross Profit Ratio 0.853-0.0290.7011.0331.1980.5470.6841.7880.5241.1820.6930.7130.7340.7270.7240.7940.7580.7450.7650.8160.8060.8220.8240.8370.8420.8530.8560.850.8620.8860.8490.9180.8670.8680.7
Reseach & Development Expenses 00000000000000000000000000000000000
General & Administrative Expenses 000000000.0340.0430.0290.0210.0440.0410.100.100.10.10.10.10.10.10.10.10.20.20.10.20.20.20.10.10
Selling & Marketing Expenses 000000000.032-0.0240.117-00.1040.1340.100.100.10.10.1-00.1-00.100.20.30.10.437.29.411.90
SG&A 000000000.0660.0190.1460.0210.1480.1750.20.10.20.10.20.20.20.10.20.10.20.10.40.50.20.63.27.49.5120
Other Expenses 8.12-000-37.043-16.18512.02840.396-59.323-00000000000000000000000000
Operating Expenses 8.1212.768-46.549-54.28137.04316.185-12.028-40.39659.323-49.350.1460.0210.1480.1750.20.10.20.10.20.20.20.10.20.10.20.10.40.50.20.63.27.49.5120
Operating Income 21.763-12.83752.27-25.945-54.731-12.19519.46832.842-55.22929.45618.6921.43623.73922.81119.53022.423.831.136.735.144.247.950.751.65957.856.657.466.636.796.459.164.60.7
Operating Income Ratio 1.361-5.4446.4070.3343.706-1.6711.79-7.775-7.072-1.3750.6880.7120.7290.7220.7170.7920.7520.7390.760.8120.8010.8190.820.8350.8390.850.850.8420.8590.880.7810.8520.7480.7320.7
Total Other Income Expenses Net 2.041-1.195-0.752-2.888-2.239-1.161-0.797-0.511-4.38-015.387-106.9473.639-6.651-5.4-23.218.1-141.8-177.6-79.1-74.8-202.587.8-13.722.2-152.9336879.1112131.2-410.7-139.288.6-8.5
Income Before Tax 23.804-14.03251.518-28.833-56.97-13.35618.67132.331-59.609034.077-85.51127.37816.1614.16.840.5-118-146.5-42.4-39.7-158.3135.73773.8-93.990.8124.6136.5178.6167.9-314.3-80.1153.2-7.8
Income Before Tax Ratio 1.488-5.9516.3150.3713.857-1.8311.717-7.654-7.632-01.255-2.8420.8410.5110.5180.1791.359-3.665-3.582-0.938-0.906-2.9312.3240.611.2-1.3531.3351.8542.0432.3593.572-2.779-1.0141.737-7.8
Income Tax Expense 0-00-0-0.086-0.071-0.056-0.055147.042030.716000000000000000000000000
Net Income 23.804-14.03251.518-28.833-56.97-13.35618.67132.331-59.60966.09234.077-85.51127.37816.1614.16.840.5-118-146.5-42.4-39.7-158.3135.73773.8-93.990.8124.6136.5178.6167.9-314.3-80.1153.2-7.8
Net Income Ratio 1.488-5.9516.3150.3713.857-1.8311.717-7.654-7.632-3.0851.255-2.8420.8410.5110.5180.1791.359-3.665-3.582-0.938-0.906-2.9312.3240.611.2-1.3531.3351.8542.0432.3593.572-2.779-1.0141.737-7.8
EPS 0.37-0.220.78-0.44-0.86-0.20.280.49-0.910.52-1.30.410.240.210.10.6-1.76-2.13-0.61-0.56-2.261.870.511.02-1.31.251.721.892.472.32-4.29-1.091.85-0.12
EPS Diluted 0.37-0.220.78-0.44-0.86-0.20.280.49-0.910.52-1.30.410.240.210.10.6-1.76-2.13-0.61-0.56-2.261.870.511.02-1.31.251.721.892.472.32-4.29-1.091.85-0.12
EBITDA 21.763-12.83752.27-25.945-54.731-12.19519.46832.842-55.22924.03249.447-192.47231.0069.4948.6-16.558.6-259.8-324.2-121.5-114.5-360.9223.523.395.9-246.9123.7192.7215.1278.9372-725.1-211.3249.3-15.7
EBITDA Ratio 1.361-5.4446.4070.3343.706-1.6711.79-7.775-7.072-1.1221.82-6.3970.9520.30.316-0.4351.966-8.068-7.927-2.688-2.614-6.6833.8270.3841.559-3.5581.8192.8683.223.6847.915-6.411-2.6752.827-15.7